Abstract
BackgroundGastrointestinal stromal tumors (GIST) represent the most common mesenchymal tumors of the gastrointestinal tract. About 85% carry an activating mutation in the KIT or PDGFRA gene. Approximately 10% of GIST are so-called wild type GIST (wt-GIST) without mutations in the hot spots. In the present study we evaluated appropriate reference genes for the expression analysis of formalin-fixed, paraffin-embedded and fresh frozen samples from gastrointestinal stromal tumors. We evaluated the gene expression of KIT as well as of the alternative receptor tyrosine kinase genes FLT3, CSF1-R, PDGFRB, AXL and MET by qPCR. wt-GIST were compared to samples with mutations in KIT exon 9 and 11 and PDGFRA exon 18 in order to evaluate whether overexpression of these alternative RTK might contribute to the pathogenesis of wt-GIST.ResultsGene expression variability of the pooled cDNA samples is much lower than the single reverse transcription cDNA synthesis. By combining the lowest variability values of fixed and fresh tissue, the genes POLR2A, PPIA, RPLPO and TFRC were chosen for further analysis of the GIST samples. Overexpression of KIT compared to the corresponding normal tissue was detected in each GIST subgroup except in GIST with PDGFRA exon 18 mutation. Comparing our sample groups, no significant differences in the gene expression levels of FLT3, CSF1R and AXL were determined. An exception was the sample group with KIT exon 9 mutation. A significantly reduced expression of CSF1R, FLT3 and PDGFRB compared to the normal tissue was detected. GIST with mutations in KIT exon 9 and 11 and in PDGFRA exon 18 showed a significant PDGFRB downregulation.ConclusionsAs the variability of expression levels for the reference genes is very high comparing fresh frozen and formalin-fixed tissue there is a strong need for validation in each tissue type. None of the alternative receptor tyrosine kinases analyzed is associated with the pathogenesis of wild-type or mutated GIST. It remains to be clarified whether an autocrine or paracrine mechanism by overexpression of receptor tyrosine kinase ligands is responsible for the tumorigenesis of wt-GIST.
Highlights
Gastrointestinal stromal tumors (GIST) represent the most common mesenchymal tumors of the gastrointestinal tract
All samples were fixed in neutral-buffered formalin prior to paraffin embedding. 20 samples from normal tissue as control group and 87 GIST representing different mutational subgroups were evalutated. 20 samples of wild type GIST (wt-GIST), 7 samples of wt-GIST associated with neurofibromatosis type 1, 20 samples with exon 9 mutation in KIT, 20 samples with exon 11 mutation in KIT and 20 samples with exon 18 mutation in PDGFRA)
We investigated in this study whether the expression of alternative receptor tyrosine kinases may contribute to the pathogenesis of wtGIST and may help to identify wt-GIST subgroups with different response to imatinib and elucidate novel therapeutic targets
Summary
Gastrointestinal stromal tumors (GIST) represent the most common mesenchymal tumors of the gastrointestinal tract. Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract and are characterized by the expression of the KIT receptor (stem cell factor receptor, CD117) and to a lesser extent of PDGFRA (platelet derived growth factor receptor alpha), representing two closely related receptor tyrosine kinases (RTK) [1,2]. In a minority of cases (10-15%) no mutations in the known KIT or PDGFRA hot spots are detected these tumors express the KIT protein. This subgroup is called wild type GIST (wt-GIST) and comprises tumors in pediatric patients, in patients affected by the Carney triad, neurofibromatosis type 1 (NF1) associated GIST and a subset of sporadic adult GIST [8,9,10,11]. The identification of additional genetic factors contributing to the pathogenesis of GIST may help to find new concepts of individualized therapy
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have